Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05497024

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

Status
Recruiting
Phase
Study type
Observational
Enrollment
45 (estimated)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
Male
Age
65 Years
Healthy volunteers
Not accepted

Summary

This protocol describes development and user testing of an educational shared decision making intervention to help men with prostate cancer who are on active surveillance make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.

Detailed description

Objectives: The overall goal of this protocol is to develop and refine an educational tool for use by patients and health-care providers to help men with localized prostate cancer make informed decisions about discontinuation of active surveillance. * Conduct cognitive and initial usability and acceptability testing of a prototype decision aid with patients * Conduct cognitive and initial usability and acceptability testing of a prototype decision aid with care partners/caregivers * Conduct expert reviews of a prototype decision aid with clinicians

Conditions

Interventions

TypeNameDescription
BEHAVIORALInterviewsParticipants will discuss background, such as race, education, and living situation. Participants will discuss Prostate cancer Participants will discuss feedback on the educational material
BEHAVIORALSurveysParticipants may answer questions that are sensitive in nature.

Timeline

Start date
2022-08-15
Primary completion
2027-02-02
Completion
2027-02-02
First posted
2022-08-11
Last updated
2026-04-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05497024. Inclusion in this directory is not an endorsement.